arBtrage CAPITALIZING MARKETS checking… Sign in

MoonLake Immunotherapeutics

MLTX Health Care Biotechnology: Pharmaceutical Preparations
$17.90
▼ -4.4% Today
as of Jun 7, 07:21 ET
Last 30 days +7.44% Apr 28 → Jun 05
$15.86 $16.75 $17.65 $18.54 $19.43 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$18.65
High
$18.74
Low
$17.66
Volume
$538,537
Avg Vol
$2M
Mkt Cap
$1.4B
P/E (TTM)
Beta
52w High
$62.75
52w Low
$5.95
Div Yield
Shares Out

Overview

52-week range
$5.95
$63
21% of range
Avg surprise (last 2)
+4.7%
Avg reaction (last 2)
+7.4%
100% positive
Latest IV / EM
84%
EM ±11.6% · $18 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.10$-0.87$-0.64$-0.41$-0.18 Actual $-0.23Actual $-0.18Actual $-0.22Actual $-0.39Actual $-0.56Actual $-0.63Est $-0.76Actual $-0.87Actual $-1.10Actual $-0.98Est $-0.91 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-70M$-59M$-48M$-37M$-25M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.98 $-0.91 -7.7% -55.6% +10.4% earnings
Tue Sep 30, 2025Sep 2025 $-1.10 financials
Mon Jun 30, 2025Jun 2025 $-0.87 financials
Mon May 12, 2025Mar/2025 $-0.63 $-0.76 +17.1% +4.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.56 financials
Sun Jun 30, 2024Jun 2024 $-0.39 financials
Sun Mar 31, 2024Mar 2024 $-0.22 financials
Sat Sep 30, 2023Sep 2023 $-0.18 financials
Fri Jun 30, 2023Jun 2023 $-0.23 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-70M$-71M$-61M$-47M$-43M$-31M
Net income$-70M$-70M$-55M$-40M$-35M$-24M
EPS (diluted)$-0.98$-1.10$-0.87$-0.63$-0.56$-0.39

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$298M$335M$351M$307M$272M$180M$376M$343M
Inventory
Total current assets$397M$422M$411M$455M$506M$474M$512M$537M
Total assets$400M$424M$414M$460M$511M$478M$518M$545M
Long-term debt$99M$74M$74M$73M$73M$0
Total liabilities$146M$120M$123M$102M$99M$25M$23M$15M
Total equity$254M$304M$289M$354M$408M$447M$488M$521M

Implied volatility — last 90 days

78%81%83%86%88% Jun 07 — IV 84% · EM ±11.6%

Sector peers